SCHEMBL7429469

SCHEMBL7429469

CC(C)Oc1ccc(C(C(CC(=O)O)C(=O)O)C(C)(C)C)cc1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.47
SMN1; SMN2 Q16637 3/20 0.44
NPSR1 Q6W5P4 1/20 0.42
KDM4E B2RXH2 1/20 0.42
CNR2 P34972 1/20 0.42
POLB P06746 2/20 0.41
MEN1 O00255 2/20 0.41
PARP10 Q53GL7 1/20 0.40
ALDH1A1 P00352 2/20 0.39
ITGB3 P05106 1/20 0.39
ITGA2B P08514 1/20 0.39
TDP1 Q9NUW8 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
MITF O75030 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
PPARG P37231 1/20 0.38
PPARA Q07869 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6576878 0.76 KMT2A (0.59) KMT2ASMN1; SMN2NPSR1KDM4ECNR2
SCHEMBL31483432 0.76 L3MBTL1 (0.64) KMT2ASMN1; SMN2NPSR1KDM4ECNR2
SCHEMBL2223462 0.74 KMT2A (0.53) KMT2ASMN1; SMN2NPSR1KDM4ECNR2
SCHEMBL7429475 0.70 POLB (0.49) KMT2AKDM4EPOLBPPARGPPARA
SCHEMBL11002192 0.70 KMT2A (0.60) KMT2ANPSR1CNR2POLBMEN1
SCHEMBL27579668 0.70 KMT2A (0.60) KMT2ACNR2POLBPARP10ALDH1A1
SCHEMBL6576876 0.70 KMT2A (0.56) KMT2AKDM4EPOLBPARP10PPARG
SCHEMBL27838831 0.70 FFAR1 (0.60) KMT2ASMN1; SMN2NPSR1KDM4ECNR2
SCHEMBL13802928 0.69 SMN1; SMN2 (0.59) KMT2ASMN1; SMN2NPSR1CNR2ALDH1A1
SCHEMBL11210075 0.69 KMT2A (0.58) KMT2ANPSR1CNR2POLBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1133484-A2 HETEROCYCLIC DERIVATIVES AND THEIR USE AS INTEGRIN INHIBITORS AstraZeneca AB (SE) 2001-09-19 EP disclosed
WO-2000005223-A2 HETEROCYCLIC DERIVATIVES AND THEIR USE AS INTEGRIN INHIBITORS ASTRAZENECA AB (SE) 2000-02-03 WO disclosed